Hill April 1, 2023
By Nathaniel Weixel

The Food and Drug Administration’s move to make a version of naloxone available without a prescription marks a major milestone in the fight against opioid addiction, and anti-addiction advocates hope it will break down barriers and help expand access to the drug.

The agency approved Narcan, the brand-name nasal spray manufactured by Emergent BioSolutions. But the company did not say how much it will charge, and there is concern that unless it is priced affordably, over-the-counter Narcan will likely have little impact on the people who need it most.

The change from prescription to over-the-counter has been a long time coming. Until now, all versions of naloxone have been available by prescription only. The agency has been encouraging...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Patient / Consumer, Pharma, Pharma / Biotech, Provider
New 'how-to guide' for future rapid vaccine development
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Sanofi adds new $600M manufacturing plant
What are the insurance commissioners talking about? 5 healthcare notes

Share This Article